{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:03:10Z","timestamp":1787169790597,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_72_20","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T06:11:56Z","timestamp":1680243116000},"page":"365-368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Heterotopic caval valve implantation in severe tricuspid regurgitation"],"prefix":"10.4103","volume":"24","author":[{"given":"Neeraj Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra Singh","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatin","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20240901","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.jacc.2016.01.063","article-title":"Transcatheter therapies for treating tricuspid regurgitation","volume":"67","author":"Rod\u00e9s-Cabau","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-16-20240901","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcvm.2018.00049","article-title":"Tricuspid regurgitation-medical management and evolving interventional concepts","volume":"5","author":"Beckhoff","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"R4-16-20240901","doi-asserted-by":"crossref","first-page":"e006061","DOI":"10.1161\/CIRCINTERVENTIONS.117.006061","article-title":"Interventional treatment of severe tricuspid regurgitation: Early clinical experience in a multicenter, observational, first-in-man study","volume":"11","author":"Lauten","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R5-16-20240901","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2013.01.070","article-title":"Percutaneous transfemoral management of severe secondary tricuspid regurgitation with edwards sapien xt bioprosthesis: First-in-man experience","volume":"61","author":"Laule","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R6-16-20240901","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcmg.2014.12.006","article-title":"Transcatheter caval valve implantation using multimodality imaging: Roles of tee, CT, and 3D printing","volume":"8","author":"O\u2019Neill","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"R7-16-20240901","first-page":"239","article-title":"Comparison of non-contrast cardiovascular magnetic resonance imaging to computed tomography angiography for aortic annular sizing before transcatheter aortic valve replacement","volume":"29","author":"Wang","year":"2017","journal-title":"J Invasive Cardiol"},{"key":"R8-16-20240901","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehr028","article-title":"Heterotopic transcatheter tricuspid valve implantation: First-in-man application of a novel approach to tricuspid regurgitation","volume":"32","author":"Lauten","year":"2011","journal-title":"Eur Heart J"},{"key":"R9-16-20240901","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ccd.26931","article-title":"Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation","volume":"90","author":"Rakita","year":"2017","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.ACA_72_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:04Z","timestamp":1787166784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.ACA_72_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_72_20","relation":{},"ISSN":["0971-9784"],"issn-type":[{"value":"0971-9784","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}